Breast cancer was diagnosed for over 7.8 million women between 2015 to 2020. Grading plays a vital role in breast cancer treatment planning. However, the current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. A recent paper leveraging volumetric deep radiomic features from synthetic correlated diffusion imaging (CDI^s) for breast cancer grade prediction showed immense promise for noninvasive methods for grading. Motivated by the impact of CDI^s optimization for prostate cancer delineation, this paper examines using optimized CDI^s to improve breast cancer grade prediction. We fuse the optimized CDI^s signal with diffusion-weighted imaging (DWI) to create a multiparametric MRI for each patient. Using a larger patient cohort and training across all the layers of a pretrained MONAI model, we achieve a leave-one-out cross-validation accuracy of 95.79%, over 8% higher compared to that previously reported.